Impact of P-gp, MRP2, ENT-1 and CNT3 on the Blood Concentration / Intra-PBMC Concentration of Tacrolimus
NCT03910868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2021-01-13
Summary
Prospective and monocentric pharmacokinetic study
Conditions
- Liver Transplantation
- Kidney Transplantation
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Principal Investigators
-
Florian LEMAITRE · Rennes University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-16
- Primary Completion
- 2020-12-16
- Completion
- 2020-12-16
Countries
- France
Study Locations
More Related Trials
-
Long-Term Pharmacokinetics of Tacrolimus in Renal Recipients
NCT00411944 ·Status: COMPLETED
-
Pharmacogenetic Study of Tacrolimus in Hepatic Transplant (CYPTAC'H)
NCT01388387 ·Status: COMPLETED ·Phase: NA
-
Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation
NCT02877628 ·Status: COMPLETED
-
Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients
NCT03020589 ·Status: COMPLETED ·Phase: PHASE4
-
Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
NCT00297310 ·Status: COMPLETED ·Phase: PHASE4
-
Genetic Factors on Outcomes of Kidney Transplant Patients With Tacrolimus-based Therapy
NCT03764670 ·Status: COMPLETED
-
Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.
NCT00296309 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients
NCT01068067 ·Status: UNKNOWN ·Phase: NA
-
Clinical Outcome of Liver Transplant Patients With Tacrolimus-based Immunosuppression
NCT03800576 ·Status: COMPLETED
-
Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients
NCT01760356 ·Status: TERMINATED
-
To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.
NCT00296361 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients
NCT03173820 ·Status: UNKNOWN ·Phase: NA
-
Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation
NCT06319391 ·Status: ACTIVE_NOT_RECRUITING
-
A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients
NCT00384137 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
NCT02453867 ·Status: UNKNOWN ·Phase: PHASE4
-
Tacrolimus Pharmacokinetic Subpopulations
NCT04526431 ·Status: RECRUITING
-
A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patients
NCT03465969 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients
NCT01256294 ·Status: COMPLETED ·Phase: PHASE4
-
Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation
NCT00935298 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
NCT00239876 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients
NCT00865137 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients
NCT02808065 ·Status: UNKNOWN
-
A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients
NCT00384202 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus
NCT00171392 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)
NCT02820259 ·Status: COMPLETED